Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan [Phase 3]
This Phase 3 trial update examines whether irbesartan can preserve residual renal function in adults with chronic kidney disease on haemodia…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating synchronised anaemia management in patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Peginesatide for Anemia in Chronic Hemodialysis Patients [Phase 2]
The document reports the completion of a Phase 2 trial evaluating peginesatide for anemia in chronic hemodialysis patients with chronic kidn…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients [Phase 2]
Phase 2 study evaluating safety, pharmacodynamics, and pharmacokinetics of multiple peginesatide doses for anemia in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
This completed observational study evaluated the time to achieve the maintenance dose of paricalcitol (Zemplar) in patients with end-stage r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease [Phase 2]
This Phase 2 trial assessed the safety of single-dose peginesatide in patients with chronic kidney disease. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of single intravenous doses of peginesatide in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism [NA]
A completed clinical trial comparing paricalcitol versus calcitriol for safety and efficacy in treating secondary hyperparathyroidism in pat…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Analysis of Calcium Balance in Chronic Kidney Disease [NA]
This document reports the completion of a clinical trial analyzing calcium balance in chronic kidney disease, with the study sponsored by th…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Role of Prohepcidin in Uremic Patients
Completed clinical trial evaluating prohepcidin in uremic patients; conditions include inflammation and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Arterial Wall Calcium Load in Pseudoxanthoma Elasticum
A clinical trial update evaluating arterial wall calcium load in Pseudoxanthoma Elasticum, with co-occurring Type 2 diabetes mellitus and ch…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)
A completed clinical trial sponsored by Genentech investigating growth failure in children with chronic kidney disease and end-stage renal d…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. [Phase 2]
Phase 2 clinical trial evaluating active vitamin D versus a phosphate binder for early-stage renal failure has been completed.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Effect of Obesity on Long-term Clinical Outcomes After Kidney Donation
Completed clinical trial evaluating the impact of obesity on long-term outcomes after kidney donation.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) [Phase 1]
Phase 1 open-label pharmacokinetic trial of iron isomaltoside 1000 (Monofer) given as a single bolus in adults with stage 5 chronic kidney d…
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy [Phase 4]
A Phase 4 clinical trial update assesses the efficacy and safety of alprostadil to prevent contrast-induced nephropathy.
-
CLINICAL_TRIALS trial_result · 2012-11-07Clinical Trial Update: Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment [Phase 1]
This Phase 1 study investigates the pharmacokinetics of dalfampridine-ER 7.5 mg taken twice daily in healthy volunteers and in people with m…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis [Phase 4]
Phase 4 trial evaluating heparin-bonded vascular grafts versus standard grafts for prosthetic arteriovenous access in hemodialysis; the stud…
-
CLINICAL_TRIALS trial_result · 2012-10-30Clinical Trial Update: A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD [NA]
A double-blind, randomized, placebo-controlled trial evaluating maintenance of normal serum phosphorus in chronic kidney disease has complet…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 trial evaluating N-acetylcysteine's effect on hydrogen sulfide in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-25Clinical Trial Update: Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients [Phase 2]
This Phase 2 trial update reports on the safety and immunomodulatory effects of alemtuzumab (Campath) in pediatric kidney transplant recipie…
-
CLINICAL_TRIALS trial_result · 2012-10-22Clinical Trial Update: Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients [Phase 4]
Phase 4 clinical trial update reporting results of aliskiren in elderly patients with hypertension and chronic kidney disease; the study has…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients [Phase 3]
A Phase 3 clinical trial update evaluating aspirin for primary cardiovascular risk prevention in adults with chronic kidney disease (stages …
-
CLINICAL_TRIALS trial_result · 2012-10-11Clinical Trial Update: N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement [Phase 2]
A Phase 2 clinical trial evaluating N-acetylcysteine for renal protection in patients with rheumatic heart disease undergoing valve replacem…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients [Phase 4]
A Phase 4 trial examining the relationship between FGF-23 and endothelial dysfunction in diabetic patients with proteinuria has completed.